Lite Strategy, Inc. Treasury Stock, Common, Value
Lite Strategy, Inc. (LITS) had Treasury Stock, Common, Value of $2.00 million as of 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:TreasuryStockCommonValue · last filed 2026-05-13
- 2026-03-31: Treasury Stock, Common, Value $2.00M.
- 2025-12-31: Treasury Stock, Common, Value $203.00K.
- 2025-06-30: Treasury Stock, Common, Value $0.00.
| Period end | Treasury Stock, Common, Value |
|---|---|
| 2026-03-31 | $2.00M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $203.00K 10-Q · filed 2026-02-17 |
| 2025-06-30 | $0.00 10-Q · filed 2026-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |